A study from Karolinska Institutet shows that Alzheimer's progression varies based on brain protein levels. Those with high amyloid-beta (Aß) and tau levels suffer more memory loss, while Aß-positive only cases have milder symptoms. Future research aims for easier tests through blood and cerebrospinal fluid analysis to enhance personalized treatments

A study from Karolinska Institutet shows that Alzheimer's progression varies based on brain protein levels. Those with high amyloid-beta (Aß) and tau levels suffer more memory loss, while Aß-positive only cases have milder symptoms. Future research aims for easier tests through blood and cerebrospinal fluid analysis to enhance personalized treatments
https://www.nature.com/articles/s41380-024-02672-9

a doc and general practitioner by day, a geopolitics junkie and deep onchain comms shitcaster by night and both in /doctorsphere

yea that's the point
early diagnosis of the disease and personalizing the treatment can be a real game-changer

Hmm can this be used in the future to screen px that have a risk for Alzheimer
Same way we usr BRCA genes now